Abstract
Several 3-alkylsulfanyl-1,2,4-triazole derivatives were synthesized and their relevant structures confirmed based on their elemental analysis and nuclear magnetic resonance. The anticancer activity of all the derivatives was evaluated for A549, MCF7, and SKOV3 cell lines by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay wherein compound 5e demonstrated significant anti-proliferative activities against all cell lines whereas 5b and 5e showed efficient anti-proliferative actions in SKOV3 cell line having half maximal inhibitory concentration (IC50) values of 0.81 and 0.53 μM, respectively. Furthermore, compound 5e was found to drive remarkable cell cycle arrest at the G2/M phase for SKOV3 cell lines in a concentration-dependent behavior. Molecular docking studies performed with these derivatives validated them as appropriate candidates for further studies of their potential anticancer activity.
Similar content being viewed by others
References
Chinthala Y, Thakur S, Tirunagari S, Chinde S, Domatti AK, Arigari NK, Srinivas KVNS, Alam S, Jonnala KK, Khan F, Ashok T, Grover P (2015). Eur J Med Chem 93:564–573
Zugazagoitia J, Gudedes C, Ponce S, Ferrer I, Molina-Pinelo S, Paz-Ares L (2016). Clin Ther 38:1551–1566
Le QV, Wu Y, Yang G, Jang HW, Shokouhimehr M, Oh YK (2019). Asian J Pharm Sci 14:16–29
Nasir RB, Varma RS (2012). Chem Commun 48:5853–5855
Huang SD, Li Y, Shokouhimehr M (2010) Gadolinium containing prussian blue nanoparticles as nontoxic MRI contrast agents having high relaxivity. U.S. Pat. 20100254
Kumar D, Reddy VB, Varma RS (2009). Tetrahedron Lett 50:2065–2068
Ruddarraju RR, Murugulla AC, Kotla R, Tirumalasetty MCB, Wudayagiri R, Donthabakthuni S, Maroju R (2017). Med Chem Commun 8:176–183
Holla BS, Veerendra B, Shivananda MK, Poojary B (2003). Eur J Med Chem 38:759–767
Turan-Zitouni G, Kaplancikli ZA, Yildiz MT, Chevallet P, Kaya D (2005). Eur J Med Chem 40:607–6013
Ezabadi IR, Camoutsis C, Zoumpoulakis P, Geronikaki A, Sokovic M, Glamocilija J, Ciric A (2008). Bioorg Med Chem 16:1150–1161
Ozdemir A, Turan-Zitouni G, Kaplancikli ZA, Chevallet PJ (2007). Enzyme Inhib Med Chem 22:511–516
Chahal MK, Dar TA, Sankar M (2018). New J Chem 42:10059–10066
Tozkoparan B, Gokhan N, Aktay G, Yesilada E, Ertan M (2000). Eur J Med Chem 35:743–750
Ned DH, Jack RRJ (1980). Heterocycl Chem 17:1087–1088
Chen J, Sun XY, Chai KY, Song MS, Quan ZS (2007). Bioorg Med Chem 15:6775–6781
Polya JB (1955). Nature 176:1175–1176
Zahran F, Abdel-Latif F, Sayed A, Shaban R, Keshta A (2013). Int J Biol Pharm Res 4:261–270
Li D, Zhang N, Dai L, Yang Z, Tao Z (2016). Appl Organomet Chem 30:346–353
Xu F, Yang Z, Ke Z, Xi L, Yan Q, Yang W, Zhu L, Lin F, Lv W, Wu H, Wang J, Li H (2016). Bioorg Med Chem Lett 26:4580–4586
Jarosław S, Aleksandra G, Beata Z, Anna K (2015). Molecules 21:41–57
Radwan A, Aboul-fadl T, Al-dhfyan A, Abdel-mageeda W (2014). Asian J Chem 26:8145–8150
Aytac P, Durmaz I, Houston D, Cetin-Atalay R, Tozkoparan B (2016). Bioorg Med Chem 24:858–872
Kleemann A, Engel J (1999) Pharmaceutical substances. Thieme, Stuttgart
Khaleghi F, Jantan I, Din LB, Yaacob WA, Khalilzadeh MA, Bukhari SNA (2014). J Nat Med 68:351–357
Rajabi M, Hossaini Z, Khalilzadeh MA, Datta S, Halder M, Mousa SA (2015). J Photochem Photobiol B 148:66–72
Rajabi M, Khalilzadeh MA, Mehrzad J (2012). DNA Cell Biol 31:128–134
Rajabi M, Khalilzadeh MA, Tavakolinia F, Signorelli P, Ghidoni R, Santaniello E (2012). DNA Cell Biol 31:783–789
Tavakolinia F, Baghipour T, Khalilzadeh MA, Hossaini Z, Rajabi M (2012). Nucleic Acids Ther 22:265–270
Meerloo J, Kaspers GJ, Cloos J (2011). Methods Mol Biol 731:237–245
Browne LJ, Gude C, Rodriguez H, Steele RE, Bhatnager AJ (1991). J Med Chem 34:725–736
Carter GP, Harjani JR, Li L, Pitcher NP, Nong Y, Riley TV, Williamson DA, Stinear TP, Baell JB, Howden BP (2018). Antimicrob Chemother 73:1562–1569
Polucci P, Magnaghi P, Angiolini M, Asa D, Avanzi N, Badari A, Bertrand J, Casale E, Cauteruccio S, Cirla A, Cozzi L, Galvani A, Jackson PK, Liu Y, Magnuson S, Malgesini B, Nuvoloni S, Orrenius C, Riccardi Sirtori F, Riceputi L, Rizzi S, Trucchi B, O’Brien T, Isacchi A, Donati D, D’Alessio R (2013). J Med Chem 56:437
Kolodina AA, Lesin AV (2009). Russ J Org 45:139
Kaplancikli ZA, Turan-Zitouni G, Chevallet P (2005). J Enzyme Inhib Med Chem 20:179
Zhao PL, Chen P, Li Q, Hu MJ, Diao PC, Pan ES, You WW (2016). Bioorg Med Chem Lett 26:3679
Zhang Q, Peng Y, Wang XI, Keenan SM, Arora S, Welsh WJ (2007). J Med Chem 50:749–754
Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS (2009). J Comput Chem 30:2785–2797
Kaur J, Kaur B, Singh P (2018). Bioorg Med Chem Lett 28:129–141
Botta M, Armaroli S, Castagnolo D, Fontana G, Pera P, Bombardell E (2007) J Bioorg Med Chem. Lett 17:1579–1583
Li YH, Zhang B, Yang HK, Li Q, Diao PC, You WW, Zhao PL (2017). Eur J Med Chem 125:1098–1106
Romagnoli R, Baraldi PG, Salvador MK, Prencipe F, Bertolasi V, Cancellieri M, Brancale A, Hamel E, Castagliuolo I, Consolaro F, Porcù E, Basso G, Viola G (2014). J Med Chem 57:6795–6808
Prota AE, Danel F, Bachmann F, Bargsten K, Buey RM, Pohlmann J, Reinelt S, Lane H, Steinmetz MO (2014). J Mol Biol 426:1848–1860
Kamal A, Srikanth PS, Vishnuvardhan MVPS, Bharath Kumar G, Suresh Babu K, Hussaini SMA, Kapure JS, Alarifi A (2016). Bioorg Chem 65:126–136
Guggilapu SD, Guntuku L, Srinivasa Reddy T, Nagarsenkar A, Sigalapalli DK, Naidu VGM, Bhargava SK, Babu Bathini N (2017). Eur J Med Chem 138:83–95
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 1779 kb)
Rights and permissions
About this article
Cite this article
Ghanaat, J., Khalilzadeh, M.A., Zareyee, D. et al. Cell cycle inhibition, apoptosis, and molecular docking studies of the novel anticancer bioactive 1,2,4-triazole derivatives. Struct Chem 31, 691–699 (2020). https://doi.org/10.1007/s11224-019-01453-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11224-019-01453-3